Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T69906 |
PEAQX sodium
|
||
PEAQX, also known as NVP-AAM077; is a competitive antagonist at the NMDA receptor. Although originally described as 100-fold selective for GluN1/GluN2A receptors vs. GluN1/GluN2B receptors, more detailed studies of the Ki of PEAQX revealed it only shows a 5 fold difference in affinity for GluN1/GluN2A vs. GluN1/GluN2B receptors. It is also a potent anticonvulsant in animal tests. | |||
T16451 |
PEAQX tetrasodium hydrate
NVP-AAM077 tetrasodium hydrate,PEAQX tetrasodium hydrate (459836-30-7 free base),PEAQX tetrasodium hydrate |
Apoptosis; NMDAR; iGluR | Apoptosis; Membrane transporter/Ion channel; Neuroscience |
PEAQX tetrasodium hydrate (PEAQX tetrasodium hydrate (459836-30-7 free base)) 是一种可口服的NMDA 拮抗剂,具有有效性和选择性。PEAQX tetrasodium hydrate (459836-30-7 free base) 对 hNMDAR 1A/2A 的 IC50 值分别为 270 nM 对hNMDAR 1A/2B 的 IC50 值为29600 nM。 | |||
T4171 |
PEAQX
NVP-AAM077 |
NMDAR; iGluR | Membrane transporter/Ion channel; Neuroscience |
PEAQX (NVP-AAM077) 是 NR2A 高效选择性 NMDA 受体拮抗剂,IC50值为270nM。 |